Improving population health or the population itself? Health technology assessment and our genetic future

Author:

Bassett Ken,Lee Patricia M.,Green Carolyn J.,Mitchell Lisa,Kazanjian Arminée

Abstract

The province of British Columbia (BC), Canada is developing its first population-wide prenatal genetic screening program, known as triple-marker screening (TMS). TMS, initiated with a simple blood test, is most commonly used to screen for fetuses with the chromosomal abnormality known as Down syndrome or neural tube disorders. Women testing TMS-positive are offered diagnostic amniocentesis and, if the diagnosis is confirmed, selective second-trimester abortion. The project described in this study was initiated to address the broad range of issues arising from this testing technology and provides an example of the new type of health technology assessment (HTA) contribution emerging (and likely to become increasing necessary) in health policy development. With the advent of prenatal genetic screening programs, would-be parents gain the promise of identifying target conditions and, hence, the option of selective abortion of affected fetuses. There is considerable awareness that these developments pose challenges in every dimension (ethical, political, economic, and clinical) of the health-care environment. In the effort to construct an appropriate prenatal screening policy, therefore, administrators have understandably sought guidance from within the field of HTA. The report authors concluded that, within the restricted path open to it, the role of government is relatively clear. It has the responsibility to maintain equal access to prenatal testing, as to any other health service. It should also require maintenance of medical standards and evaluation of program performance. At the same time, policy-makers need actively to support those individuals born with disabilities and their families.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy

Reference32 articles.

1. Baillie C , Hewison J .1999 Antenatal screening: Obtaining selective consent to scanning, rather than screening, is possible. Letter.BMJ.318:805.

2. Stephenson P , Mitchell L .1998 Social and cultural determinants of parental experiences with ultrasound detected foetal anomalies.British Columbia:British Columbia Medical Services Foundation Grant No. BCM98-0012.

3. Royal Commission on New Reproductive Technologies.1993 Prenatal Diagnosis for Congenital Anomalies and Genetic Disease.In: Proceed with care. Final report of the Royal Commission on New Reproductive Technologies,vol. 2.804.

4. Asch A .1999 Prenatal diagnosis and selective abortion: A challenge to practice and policy.Am J Public Health.89:1649–1657.

5. Palomaki GE , Knight GJ , McCarthy JE , Haddow JE , Donhowe JM .1997 Maternal serum screening for Down syndrome in the United States: A 1995 survey.Am J Obstet Gynecol.176:1046–1051.

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3